Avastin wins full green light for glioblastoma

7th December 2017 Uncategorised 0

Roche group Genentech has announced full US approval for Avastin for the treatment of adults with glioblastoma that progressed following prior therapy.

More: Avastin wins full green light for glioblastoma
Source: News